Pharvaris (PHVS) Curent Deferred Tax Liability (2021 - 2023)
Pharvaris (PHVS) posted Curent Deferred Tax Liability of $169756.8 for Q2 2023, down 63.93% on a QoQ basis from $470642.2 in Q4 2022, and down 94.33% year-over-year from $3.0 million in Q2 2022.
Pharvaris (PHVS) Curent Deferred Tax Liability (2021 - 2023) Analysis & Trends
Pharvaris' Curent Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $169756.8 for Q2 2023.
- Quarterly Curent Deferred Tax Liability fell 94.33% year-over-year to $169756.8 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $169756.8 (down 94.33% YoY) and the FY2022 annual result came in at $486192.0, up 225.66% from the prior year.
- Curent Deferred Tax Liability was $169756.8 for Q2 2023 at Pharvaris, down from $470642.2 in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $3.0 million in Q2 2022 and bottomed at $144319.9 in Q4 2021.
- A 3-year average of $833525.6 and a median of $388235.0 in 2022 frame the typical range for Curent Deferred Tax Liability.
- Annual changes were most pronounced in 2022 — Curent Deferred Tax Liability jumped 226.11% — and 2023, when it sank 94.33%.
- Pharvaris' Curent Deferred Tax Liability stood at $144319.9 in 2021, then soared by 226.11% to $470642.2 in 2022, then tumbled by 63.93% to $169756.8 in 2023.
- Business Quant data shows PHVS's Curent Deferred Tax Liability at $169756.8 in Q2 2023, $470642.2 in Q4 2022, and $388235.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 169,756.78 |
| Jun 30, 2023 | 169,756.78 |
| Dec 31, 2022 | 470,642.15 |
| Dec 31, 2022 | 470,642.15 |
| Sep 30, 2022 | 388,235.02 |
| Sep 30, 2022 | 388,235.02 |
| Jun 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 2.99 Mn |
| Dec 31, 2021 | 144,319.94 |
| Dec 31, 2021 | 144,319.94 |